Amneal Pharmaceuticals Inc

AMRX

Company Profile

  • Business description

    Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

  • Contact

    400 Crossing Boulevard
    3rd Floor
    BridgewaterNJ08807
    USA

    T: +1 908 947-3120

    E: [email protected]

    https://www.amneal.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    8,100

Stocks News & Analysis

stocks

2 ASX shares that benefit from sticky inflation

Inflation is a key risk to shareholders. Here’s why these two ASX shares benefit from higher inflation.
stocks

Our view of Dexus / Scentre deal

Dexus acquires stake in Westfiend Chermside.
stocks

Undervalued ASX retailer benefiting from rebound in spending

Uplift in sales momentum continues.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,869.4021.000.24%
CAC 408,106.160.000.00%
DAX 4024,076.87153.04-0.63%
Dow JONES (US)48,114.26302.30-0.62%
FTSE 1009,684.7966.52-0.68%
HKSE25,261.5626.150.10%
NASDAQ23,111.4654.050.23%
Nikkei 22549,442.6259.330.12%
NZX 50 Index13,385.1339.82-0.30%
S&P 5006,800.2616.25-0.24%
S&P/ASX 2008,581.0017.400.20%
SSE Composite Index3,831.306.490.17%

Market Movers